Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
132
-
Total shares
-
26.3M
-
Shares change
-
+2.43M
-
Total reported value, excl. options
-
$591M
-
Value change
-
+$55.5M
-
Number of buys
-
76
-
Number of sells
-
-43
-
Price
-
$22.46
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2020
131 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q2 2020.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
of 50.5M outstanding shares and own 52.16% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.61M shares), FEDERATED HERMES, INC. (2.6M shares), VANGUARD GROUP INC (2.39M shares), DIMENSIONAL FUND ADVISORS LP (1.84M shares), Invesco Ltd. (1.27M shares), STATE STREET CORP (1.26M shares), FULLER & THALER ASSET MANAGEMENT, INC. (815K shares), GEODE CAPITAL MANAGEMENT, LLC (541K shares), NORDEA INVESTMENT MANAGEMENT AB (528K shares), and NORTHERN TRUST CORP (522K shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.